Codexis, Inc. (NASDAQ:CDXS) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Codexis Fourth Quarter and Full Year 2022 Earnings Conference Call. A question-and-answer session will follow the formal presentation. .
Posts Tagged ‘NASDAQ:CDXS’
15 Worst Stock Picks of Cathie Wood in 2022
In this piece, we will take a look at the 15 worst stock picks of Cathie Wood in 2022.
10 Small-Cap Growth Stocks in Cathie Wood’s Portfolio
In this article, we discuss 10 small-cap growth stocks in Cathie Wood's portfolio.
‘We Will Shine’: Cathie Wood’s Optimism and Her 10 Most Ambitious Stock Picks
In this article, we discuss Cathie Wood’s optimism and her 10 most ambitious stock picks.
10 Biotech Stocks to Sell Now According to Cathie Wood
In this article, we discuss 10 biotech stocks to sell now according to Cathie Wood.
Hedge Funds Have Never Been This Bullish On Codexis, Inc. (CDXS)
In this article we will take a look at whether hedge funds think Codexis, Inc. (NASDAQ:CDXS) is a good investment right now.
11 Best Aggressive Stocks To Buy Now
In this article, we discuss the 11 best aggressive stocks to buy now.
Cathie Wood’s Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
10 Best Cheap Tech Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best tech stocks to buy according to Cathie Wood.
Codexis (CDXS) is Roubaix Capital’s Star Performer During the Q4 of 2020
Roubaix Capital LLC, an investment management firm, published its 'Roubaix Fund Composite' fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here.
Wednesday’s 10 Notable Stocks in Focus
U.S. stock futures tied to all three major indexes rose in the premarket trading Wednesday. At 2:18 p.m.
Hedge Funds Are Selling Codexis, Inc. (CDXS)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Are Dumping Codexis, Inc. (CDXS)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is Codexis, Inc. (CDXS) A Good Stock To Buy ?
How do we determine whether Codexis, Inc.
Hedge Funds Have Never Been This Bullish On Codexis, Inc. (CDXS)
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost nearly 40% of its value at one point in 2018.
Hedge Fund and Insider Trading News: Tom Steyer, Odey Asset Management, Netflix, Inc. (NFLX), Codexis, Inc. (CDXS), Appian Corp (APPN), and More
Hedge fund billionaire Tom Steyer is spending millions of dollars to turn politically-red Arizona green in a battle that’s growing increasingly nasty.
Hedge Fund and Insider Trading News: Carl Icahn, Barings BDC Inc (BBDC), Pure Storage Inc (PSTG), Herman Miller, Inc. (MLHR), and More
In 2013, Michael Dell and his private-equity backers at Silver Lake took Dell Inc. private for about $25 billion.
Here’s What Is Going On In The Financial Markets Today?
"Stocks rose slightly on Friday afternoon as investors parsed through a mixed employment report, a U.S. airstrike in Syria and comments from a top Federal Reserve official.
BP plc (ADR) (BP) & More: Gevo, Inc. (GEVO) Begins Countdown to Ethanol’s End
There have been two pops of at least 20% for industrial biotech in the last week -- both on the heels of expected news, nonetheless. Last week Codexis, Inc.
BASF Se-spon Adr (BASFY), Codexis, Inc. (CDXS): World’s Largest Chemical Company Makes a Splash in Enzymes
It was only a matter of time.
Codexis, Inc. (CDXS): This Biotech Stock Keeps Investors Patiently Waiting
Synthetic biology company and industrial bio-enzyme manufacturer Codexis, Inc. (NASDAQ:CDXS) announced its first-quarter earnings after the market closed Tuesday.
Valero Energy Corporation (VLO), BP plc (ADR) (BP), Codexis, Inc. (CDXS): Why Big Oil Is Ditching Biotechnology
Landing partners with deep pockets will be critical for many developmental stage biotechnology companies looking to take their disruptive platforms to the next level.
Microsoft Corporation (MSFT), Intel Corporation (INTC), GlaxoSmithKline plc (ADR) (GSK): 8 Projects Bringing Synthetic Biology to Your Doorstep
Bacteria have been Public Enemy No. 1 for most of our species' time on Earth.
Codexis, Inc. (CDXS) Eyes Raizen With Latest Enzymes: Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Aside from a former partnership with Royal Dutch Shell plc (ADR) (NYSE:RDS-A), industrial biotechnology company Codexis, Inc.
A Tough Road Ahead for This Big Pharma Partner: Codexis, Inc. (CDXS), Royal Dutch Shell plc (ADR) (RDS.A)
Bio-based enzyme producer Codexis, Inc. (NASDAQ:CDXS) reported financial results for the fourth quarter and full-year 2012 last week.
What Does Solazyme Inc (SZYM)’s 500,000-Liter Fermenter Really Mean?
At the end of 2012, renewable-oils manufacturer Solazyme Inc (NASDAQ:SZYM) announced that it had performed two upstream process runs in 500,000-liter fermenters.
3 Reasons to Buy Solazyme Inc (SZYM)
When you go out to a restaurant, would you rather read through a menu with limited options or one with exponential potential to send you into a food coma? Perhaps you have more...
